CYBIN INC. (HELP) Form 6-K — Sep 3, 2026

Helus Pharma (Nasdaq: HELP; Cboe Canada: HELP), the commercial operating name of Cybin Inc., announced its participation at the 2026 Cantor Global Healthcare Conference in New York City, taking place September 9-11, 2026. Chief Executive Officer Michael Halstead will participate in a fireside chat on Friday, September 11, 2026 at 8:00 a.m. EDT, with a live webcast and replay available on the company's investor relations website.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.